Birchview Capital’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,000
| Closed | -$153K | – | 75 |
|
|
2025
Q1 | $153K | Hold |
15,000
| – | – | 0.13% | 55 |
|
|
2024
Q4 | $237K | Buy |
15,000
+8,000
| +114% | +$127K | 0.19% | 54 |
|
|
2024
Q3 | $406K | Hold |
7,000
| – | – | 0.35% | 31 |
|
|
2024
Q2 | $320K | Hold |
7,000
| – | – | 0.3% | 43 |
|
|
2024
Q1 | $463K | Hold |
7,000
| – | – | 0.38% | 36 |
|
|
2023
Q4 | $278K | Hold |
7,000
| – | – | 0.22% | 43 |
|
|
2023
Q3 | $223K | Hold |
7,000
| – | – | 0.19% | 45 |
|
|
2023
Q2 | $281K | Hold |
7,000
| – | – | 0.21% | 47 |
|
|
2023
Q1 | $299K | Hold |
7,000
| – | – | 0.23% | 44 |
|
|
2022
Q4 | $336K | Buy |
+7,000
| New | +$336K | 0.24% | 41 |
|